Pharmafile Logo
Pharmafocus logo
Advanced Search
Sandy Royden

Sandy Royden steps down from Huntsworth

February 9, 2010
Medical Communications Huntsworth, appointment, medical communications

Huntsworth Health’s European chief executive Sandy Royden is stepping down at the end of March. Sandy, who is expecting a …

Appointment

ICON promotes Tom O’Leary

February 9, 2010
Research and Development ICON, appointment, research and development

Tom O’Leary has been appointed president of ICON Central Laboratories, succeeding Bob Scott-Edwards. Scott-Edwards had held the role since August …

Appointment
Novartis' Olivier Leupin

Working Life: Olivier Leupin

February 9, 2010
Business Services, Research and Development Novartis, Working Life, careers, careers voice

How did you find your way into your most current role? After receiving a master’s degree in biology at the …

Feature

Huntsworth reorganises European health offering

February 9, 2010
Medical Communications Huntsworth

Huntsworth Health has completed a reshuffle of its European operations that sees the company align its operations under three brands. …

News

Ranbaxy woes revealed in FDA warning letter

February 9, 2010
Manufacturing and Production Ranbaxy

Ranbaxy has not taken adequate measures to correct deficiencies at its manufacturing plants, according to a communication from the US …

News

PharmaIntel appoints Jacqui Batchelor

February 8, 2010
Business Services, Sales and Marketing PharmaIntel, appointment, sales and marketing

PharmaIntel, the commercial excellence consultancy founded by Gary Killington in 2008, has appointed two new team members to manage the delivery …

Appointment

Pfizer launches e-payment scheme for emerging markets

February 8, 2010
Sales and Marketing Pfizer, discount, em, emerging markets

Pfizer is reaching further into emerging markets with the launch of an e-payment scheme that offers patients deep discounts on …

News

Roche expands Herceptin franchise

February 8, 2010
Sales and Marketing Herceptin, Roche, gastric cancer, stomach cancer

Roche’s blockbuster breast cancer treatment Herceptin has been launched in the UK as a treatment for stomach cancer. It is …

News

Pfizer to personalise brain tumour vaccine

February 8, 2010
Research and Development Pfizer, Qiagen, brain tumour, gliobastoma, vaccines

Pfizer is working with Dutch company Qiagen to develop a companion diagnostic kit for its immunotherapy vaccine for gliobastoma multiforme. …

News
Blog footer

Digital Pharma: UCB’s online epilepsy community

February 8, 2010
Medical Communications, Research and Development PatientsLikeMe, UCB, community, digital pharma, digital pharma research, patient information

UCB has launched an online community for US epilepsy patients to record ‘real-world’ experiences of the condition. In addition to …

Feature

Generics firm press for ‘clear and open’ market

February 8, 2010
Sales and Marketing generics, industry

Generic drug companies have set out their vision of a more ‘clear’ and ‘open’ market in Europe. Greg Perry, director …

News

Carbogen Amcis opens large-scale high-potency API plant

February 8, 2010
Manufacturing and Production Carbogen Amcis, Dishman, India

Carbogen Amcis, the Swiss subsidiary of Dishman Pharmaceuticals and Chemicals of India, has opened a new high-potency active pharmaceutical ingredient …

News

GSK appoints Philippe Fauchet president of GSK Japan

February 8, 2010
Sales and Marketing GlaxoSmithKline, appointment, sales and marketing

GSK has appointed Philippe Fauchet president of GSK Japan, reporting to to Marc Dunoyer who takes a new role as …

Appointment

Pharma manufacturing news in brief

February 8, 2010
Manufacturing and Production, Medical Communications Angel Biotech, Catalent, Enzon, Genzyme, Gorbec Pharmaceuticals Services, Peakdale Molecular, Pfizer, Sigma-Tau, Synco Bio Partners

Our round-up of news in the pharmaceutical manufacturing arena covers developments at Genzyme, Enzon/Sigma-Tau, Catalent, Synco Bio Partners, Angel Biotech, …

News
UK swine flu leaflet

UK swine flu cases fall

February 5, 2010
Sales and Marketing h1n1, swine flu

The government has warned against complacency over swine flu as it released figures showing UK cases had fallen to one …

News

GSK looks to rare diseases research

February 5, 2010
Research and Development GlaxoSmithKline, Orphan

GlaxoSmithKline has launched a new specialist unit to research and develop medicines for rare diseases. The company has identified 5,500 …

News
Cohn and Wolfe Mike Kan

Cohn & Wolfe appoints Mike Kan

February 5, 2010
Medical Communications Cohn & Wolfe, appointment, medical communications

Cohn & Wolfe has appointed Mike Kan as global healthcare practice leader. He assumes the role from Linda Dyson who …

Appointment

Recipharm charms Cobra shareholders into selling up

February 5, 2010
Manufacturing and Production Cobra, Recipharm, Wasserburger

Swedish contract development and manufacturing organisation (CDMO) Recipharm has said that its takeover bid for UK company Cobra Biomanufacturing has …

News
ABPI

Barker praises OLS model

February 5, 2010
Research and Development, Sales and Marketing ABPI, Blueprint, OLS

The ABPI’s director general spoke to Pharmafocus about the promise of the new Blueprint at its launch in London last …

News
Andrew Witty

GSK confirms job cuts but avoids specifics

February 5, 2010
Research and Development, Sales and Marketing 2009 financials, GlaxoSmithKline

GlaxoSmithKline has sidestepped questions about the internal fall-out from its new plan to slash R&D infrastructure costs. Presenting the company’s …

News
The Gateway to Local Adoption Series

Latest content

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026